創建宗旨

蘇州生物醫藥轉化工程中心（以下簡稱“轉化中心”）以生物醫藥創新藥為主導，專注于從新藥候選物的篩選優化到臨床前研究等新藥研發的重要階段，力爭成為具有國際影響力的創新藥物研發中心。“轉化中心”通過 “人才、產業、資本”三位一體平臺型創新體系，培養具有創新精神和創業能力的優秀人才，促進科技成果轉移孵化，形成開放式創新創業生態系統。“轉化中心”致力于促進國內外的交流合作，了解藥物研發的最新發現和需求并保證研發項目的創新性和先進性；推動項目的引進，聯合開發和產業轉化。“轉化中心”建立了完善的以投資不同階段的孵化企業的資本管理體系，形成“技術吸引資本，資本成就產業，產業促進資本升值，資本收益反哺技術”良性的產業發展生態。

Mission

Suzhou Institute for Biomedical Research (SZIBR) dedicated to developing the next generation of medicines accelerated by world-class drug discovery and development capabilities. As a biomedical research hub, SZIBR’s research interests approach a broad range of human diseases, including cancer, metabolic and cardiovascular diseases, infectious and neglected diseases etc. SZIBR is bridging the gap between academia and industry, establishing a symbiotic relationship that has led to innovative research and commercialization.